Cigna is one step closer to dropping its Medicare business this week after finalizing the sale of its MA plans to the Health Care Service Corp. (HCSC) for $3.3 billion, so long as federal regulators approve the deal. It is set to finalize by the first quarter of 2025.
Late last year, the insurance giant was scrambling to find...National News
Drugs with alternative drug codes, including hepatitis C treatments Epclusa (sofosbuvir/velpatasvir) and Harvoni (ledipasvir/sofosbuvir) will be among the first listed on the new formulary when released January 1. 2019.
The formulary is available for commercial plans only. It's a move the pharmacy benefit manager is betting will gain...News
Absorbing Express Scripts, the nation’s largest pharmacy benefit manager, could further reshape the roiling health care landscape.
The deal would mark the end of the last major independent pharmacy benefit manager, one that has focused on striking deals with drug companies to lower costs for insurers and employers. Express Scripts...
The potential merger between CVS and Aetna could be worth more than $66 billion.
The online retailer Amazon's flirtation with the pharmacy business has been raised as a factor in the merger. But many industry experts say CVS and Aetna have another huge competitor on their minds: UnitedHealth Group. Kaiser Health News quotes Ana Gupte,...